Picture of Aceso Life Science logo

474 Aceso Life Science News Story

0.000.00%
hk flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapNeutral

Brief: Hao Tian Development Says On 13 July, Unit & Promethera Biosciences Entered JV Deal For Formation Of JV Co

July 14 (Reuters) - Hao Tian Development Group Ltd
 0474.HK :
    * HAO TIAN DEVELOPMENT- ON 13 JULY, UNIT & PROMETHERA
BIOSCIENCES
ENTERED JV DEAL FOR FORMATION OF JV CO
    * HAO TIAN DEVELOPMENT- JV SHALL BE OWNED AS TO 60% BY ACESO
LIFE
SCIENCE AND 40% BY PROMETHERA BIOSCIENCES
    * HAO TIAN DEVELOPMENT- JV TO DEVELOP BIOLOGICAL THERAPIES
FOR
TREATMENT OF LIVER DISEASES, AUTOIMMUNE DISEASES & TYPES OF
CANCER
    * HAO TIAN DEVELOPMENT- CO TO SUBSCRIBE FOR CONVERTIBLE
BONDS UP
TO EURO 10 MILLION

Further company coverage:  0474.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aceso Life Science

See all news